FIELD: medicine, hematology. SUBSTANCE: method involves the use of the known medicinal agent pentamine as an agent stimulating erythroid and granulocyte erythropoiesis stems at cytostatic myelodepressions. EFFECT: decreased toxicity of cytostatics. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
AGENT STIMULATING ERYTHROIDAL AND GRANULOCYTIC HEMOPOIESIS STEMS IN CYTOSTATIC MYELODEPRESSION | 2003 |
|
RU2243782C1 |
ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
PREPARATION PREVENTING DEVELOPMENT OF DEPRESSION OF ERITHROID HEMATOPOIESIS SHOOT WITH INTRODUCTION OF CYTOSTATIC | 2007 |
|
RU2354376C1 |
Authors
Dates
1997-07-10—Published
1993-07-01—Filed